In January 2012, the firm completed a $665 million transaction where it acquired the overseas healthcare assets owned by its own promoters in a deal part funded by Singh brothers.
The ophthalmic lens maker has been following a string-of-pearls acquisition strategy in India and globally.
India's No. 1 pharmaceutical company Ranbaxy has said it is planning to appeal to the EU General Court in Luxembourg, Europe's second-highest, after it was fined 10.3 million euros.
Healthspring is looking to raise another Rs 50 crore by the end of this year to expand to 170 centres across the country in the next 3.5 years.
This would be the second strategic exit for Fortis after it sold stake in Australia-based Dental Corporation to Bupa Australia Health for $286m.